Literature DB >> 8972713

Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin.

D R Senger1, C A Perruzzi.   

Abstract

Osteopontin (OPN) is a secreted adhesive glycoprotein with a gly-arg-gly-asp-ser (GRGDS) cell binding domain. Several independent studies have suggested that OPN functions in tumor growth and metastasis, and one likely possibility is that OPN facilitates tumor invasion by promoting tumor cell migration. Consistent with this hypothesis, immobilized OPN promoted concentration-dependent tumor cell migration (i.e., haptotaxis) in modified Boyden chambers. In particular, cleavage of OPN by thrombin, which likely occurs in the tumor microenvironment, resulted in enhancement of OPNs haptotactic activity; and assays performed with purified preparations of the two individual OPN thrombin-cleavage fragments demonstrated that all detectable activity was associated with the GRGDS-containing fragment. In contrast to the activity of both OPN and its GRGDS-containing fragment in promoting haptotaxis, neither of these proteins in solution promoted chemotaxis, indicating that each must be immobilized to promote cell migration. In haptotaxis assays, antibody LM609 to integrin alpha v beta 3 blocked > 80% cell migration towards the GRGDS-containing OPN fragment, implicating alpha v beta 3 as its principal functional receptor. In comparison with equimolar quantities of other adhesive proteins, the GRGDS-containing OPN thrombin-cleavage fragment was not only > 2-fold more effective than intact OPN at promoting haptotaxis, but also > 8-fold and > 6-fold more effective than fibrinogen and vitronectin, respectively, indicating that this OPN fragment is highly active relative to other alpha v beta 3 ligands.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8972713     DOI: 10.1016/s0167-4889(96)00067-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  37 in total

1.  Silencing of skeletal metastasis-associated genes impairs migration of breast cancer cells and reduces osteolytic bone lesions.

Authors:  Christina Reufsteck; Rinat Lifshitz-Shovali; Michael Zepp; Tobias Bäuerle; Dieter Kübler; Gershon Golomb; Martin R Berger
Journal:  Clin Exp Metastasis       Date:  2012-03-11       Impact factor: 5.150

2.  The isolation and characterization of glycosylated phosphoproteins from herring fish bones.

Authors:  Hai-Yan Zhou; Erdjan Salih; Melvin J Glimcher
Journal:  J Biol Chem       Date:  2010-09-10       Impact factor: 5.157

3.  Potential roles of osteopontin and alphaVbeta3 integrin in the development of coronary artery restenosis after angioplasty.

Authors:  D Panda; G C Kundu; B I Lee; A Peri; D Fohl; I Chackalaparampil; B B Mukherjee; X D Li; D C Mukherjee; S Seides; J Rosenberg; K Stark; A B Mukherjee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 4.  Customizable biomaterials as tools for advanced anti-angiogenic drug discovery.

Authors:  Eric H Nguyen; William L Murphy
Journal:  Biomaterials       Date:  2018-07-26       Impact factor: 12.479

5.  Progesterone and placentation increase secreted phosphoprotein one (SPP1 or osteopontin) in uterine glands and stroma for histotrophic and hematotrophic support of ovine pregnancy.

Authors:  Kathrin A Dunlap; David W Erikson; Robert C Burghardt; Frank J White; Kristey M Reed; Jennifer L Farmer; Thomas E Spencer; Ronald R Magness; Fuller W Bazer; Kayla J Bayless; Greg A Johnson
Journal:  Biol Reprod       Date:  2008-07-30       Impact factor: 4.285

6.  Modulation of bone resorption by phosphorylation state of bone sialoprotein.

Authors:  Paul Curtin; Kevin P McHugh; Hai-Yan Zhou; Rudolf Flückiger; Paul Goldhaber; Frank G Oppenheim; Erdjan Salih
Journal:  Biochemistry       Date:  2009-07-28       Impact factor: 3.162

Review 7.  Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies.

Authors:  Lunxiu Qin
Journal:  Front Med       Date:  2014-01-25       Impact factor: 4.592

8.  Genomic aberrations in hepatocellular carcinoma related to osteopontin expression detected by array-CGH.

Authors:  Jin-Cai Wu; Bing-Sheng Sun; Ning Ren; Qing-Hai Ye; Lun-Xiu Qin
Journal:  J Cancer Res Clin Oncol       Date:  2009-10-16       Impact factor: 4.553

9.  Enhancement of pig embryonic implants in factor VIII KO mice: a novel role for the coagulation cascade in organ size control.

Authors:  Anna Aronovich; Dalit Tchorsh; Elias Shezen; Chava Rosen; Yael Klionsky; Sivan Cohen; Orna Tal; Uri Martinowitz; Helena Katchman; Smadar Eventov-Friedman; Ninette Amariglio; Jasmine Jacob-Hirsch; Gideon Rechavi; Yair Reisner
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

10.  The role of osteopontin in inflammatory processes.

Authors:  Susan Amanda Lund; Cecilia M Giachelli; Marta Scatena
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.